BC
KNTE
Boxer Capital’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-491,000
| Closed | -$1.49M | – | 81 |
|
|
2023
Q2 | $1.49M | Sell |
491,000
-19,000
| -4% | -$57.6K | 0.07% | 70 |
|
|
2023
Q1 | $3.19M | Hold |
510,000
| – | – | 0.16% | 58 |
|
|
2022
Q4 | $3.11M | Sell |
510,000
-1,012,559
| -67% | -$6.18M | 0.16% | 54 |
|
|
2022
Q3 | $18.2M | Sell |
1,522,559
-325,000
| -18% | -$3.88M | 1.02% | 36 |
|
|
2022
Q2 | $23.3M | Hold |
1,847,559
| – | – | 1.48% | 25 |
|
|
2022
Q1 | $20.8M | Hold |
1,847,559
| – | – | 1.07% | 29 |
|
|
2021
Q4 | $32.7M | Hold |
1,847,559
| – | – | 1.27% | 20 |
|
|
2021
Q3 | $42.5M | Buy |
1,847,559
+781,620
| +73% | +$18M | 1.49% | 19 |
|
|
2021
Q2 | $24.8M | Hold |
1,065,939
| – | – | 0.88% | 33 |
|
|
2021
Q1 | $33.2M | Buy |
1,065,939
+1,274
| +0.1% | +$39.7K | 1.13% | 30 |
|
|
2020
Q4 | $42.4M | Buy |
+1,064,665
| New | +$42.4M | 1.36% | 21 |
|